Assignee
ZOMAGEN BIOSCIENCES LTD
US·3 granted patents·4 pending applications·0 citations·filing 2020–2023
Top patents by PatentIndex Score
7 records- 0176US2024101571A1Nlrp3 modulatorsZOMAGEN BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 0273US2023183258A1Nlrp3 modulatorsZOMAGEN BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 0366US11603375B2NLRP3 modulatorsZOMAGEN BIOSCIENCES LTD·Filed 2021·Granted Mar 14, 2023·0 cites·20 claims
- 0455US2023295113A1Nlrp3 modulatorsZOMAGEN BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 0552US2024327413A1Nlrp3 modulatorsZOMAGEN BIOSCIENCES LTD·Filed 2022·Application pending·0 cites
- 0651US12466800B2N-((1,2,3,5,6,7-hexahydro-S-indacen-4-yl)carbamoyl)-4, 5, 6, 7-tetrahydrobenzofuran-2-sulfonamide derivatives and related compounds as NLPR3 modulators for the treatment of multiple sclerosis (MS)ZOMAGEN BIOSCIENCES LTD·Filed 2020·Granted Nov 11, 2025·0 cites·19 claims
- 0751US12351564B2NLRP3 modulatorsZOMAGEN BIOSCIENCES LTD·Filed 2020·Granted Jul 8, 2025·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when ZOMAGEN BIOSCIENCES LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →